Satralizumab in the treatment of neuromyelitis optica spectrum disorder
A Duchow, J Bellmann-Strobl - Neurodegenerative Disease …, 2021 - Future Medicine
Neuromyelitis optica spectrum disorder (NMOSD) is a rare and debilitating autoimmune
astrocytopathy with a predominantly relapsing disease course. Satralizumab, a humanized …
astrocytopathy with a predominantly relapsing disease course. Satralizumab, a humanized …
Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders
A Duchow, F Paul, J Bellmann-Strobl - Expert Opinion on Biological …, 2020 - Taylor & Francis
Introduction Treatment options for patients suffering from neuromyelitis optica spectrum
disorders (NMOSD) so far have relied on off-label and empiric drugs. The first drug for the …
disorders (NMOSD) so far have relied on off-label and empiric drugs. The first drug for the …
Time to disability milestones and annualized relapse rates in NMOSD and MOGAD
A Duchow, J Bellmann‐Strobl, T Friede… - Annals of …, 2024 - Wiley Online Library
Objective To investigate accumulation of disability in neuromyelitis optica spectrum disorder
(NMOSD) and myelin oligodendrocyte glycoprotein‐antibody‐associated disease (MOGAD) …
(NMOSD) and myelin oligodendrocyte glycoprotein‐antibody‐associated disease (MOGAD) …
Emerging drugs for the treatment of neuromyelitis optica
Introduction Evidence-based treatment options for neuromyelitis optica spectrum disorders (NMOSD)
patients are beginning to enter the market. Where previously, there was only the …
patients are beginning to enter the market. Where previously, there was only the …
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
…, D Leppert, N Siebert, AS Duchow… - Journal of …, 2021 - Springer
Background Neuromyelitis optica spectrum disorder (NMOSD) is a frequently disabling
neuroinflammatory syndrome with a relapsing course. Blood-based disease severity and …
neuroinflammatory syndrome with a relapsing course. Blood-based disease severity and …
Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis
…, S Reimann, S Asseyer, A Duchow… - Neurology …, 2022 - AAN Enterprises
Background and Objectives The choroid plexus has been shown to play a crucial role in
CNS inflammation. Previous studies found larger choroid plexus in multiple sclerosis (MS) …
CNS inflammation. Previous studies found larger choroid plexus in multiple sclerosis (MS) …
Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
…, P Schindler, C Alvarez-González, AS Duchow… - Journal of …, 2022 - Springer
Background In neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte
glycoprotein antibody-associated disease (MOGAD), neutrophils are found in CNS lesions…
glycoprotein antibody-associated disease (MOGAD), neutrophils are found in CNS lesions…
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients
L Ostendorf, P Dittert, R Biesen, A Duchow… - Scientific Reports, 2021 - nature.com
We aimed to evaluate SIGLEC1 (CD169) as a biomarker in multiple sclerosis (MS) and
Neuromyelitis optica spectrum disorder (NMOSD) and to evaluate the presence of SIGLEC1 + …
Neuromyelitis optica spectrum disorder (NMOSD) and to evaluate the presence of SIGLEC1 + …
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases: COPANMO (G)-Study
…, F Paul, J Bellmann-Strobl, A Duchow… - Neurology …, 2023 - AAN Enterprises
Background and Objectives To evaluate the effects of the coronavirus disease 2019 (COVID-19)
pandemic on the life of patients with neuromyelitis optica spectrum disorders (NMOSD) …
pandemic on the life of patients with neuromyelitis optica spectrum disorders (NMOSD) …
Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in neuromyelitis optica spectrum disorder
O Schmetzer, E Lakin, B Roediger, A Duchow… - Frontiers in …, 2021 - frontiersin.org
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a clinically defined,
inflammatory central nervous system (CNS) disease of unknown cause, associated with humoral …
inflammatory central nervous system (CNS) disease of unknown cause, associated with humoral …
